Neurocysticercosis
Neurocysticercosis is a topic covered in the Washington Manual of Medical Therapeutics.
To view the entire topic, please log in or purchase a subscription.
The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
- Neurocysticercosis should be suspected in patients from Mexico and Central and South America who present with seizures.
- Ingested eggs of Taenia solium differentiate into larvae, which disseminate to brain and other tissues and form cysts.
- Brain imaging reveals characteristic multiple unilocular cysts that eventually calcify.
- Treatment consists of anticonvulsants, albendazole or praziquantel, with concomitant glucocorticoids to decrease the inflammatory response, and/or surgery.1
-- To view the remaining sections of this topic, please log in or purchase a subscription --
- Neurocysticercosis should be suspected in patients from Mexico and Central and South America who present with seizures.
- Ingested eggs of Taenia solium differentiate into larvae, which disseminate to brain and other tissues and form cysts.
- Brain imaging reveals characteristic multiple unilocular cysts that eventually calcify.
- Treatment consists of anticonvulsants, albendazole or praziquantel, with concomitant glucocorticoids to decrease the inflammatory response, and/or surgery.1
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Neurocysticercosis." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602366/2/Neurocysticercosis.
Neurocysticercosis. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602366/2/Neurocysticercosis. Accessed February 6, 2023.
Neurocysticercosis. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602366/2/Neurocysticercosis
Neurocysticercosis [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 February 06]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602366/2/Neurocysticercosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neurocysticercosis
ID - 602366
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602366/2/Neurocysticercosis
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -